Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2666]

Supercharged natural killer cells suppress solid tumours in mice

Supercharged natural killer cells suppress solid tumours in mice

Machine learning model improves accuracy of liquid biopsy results

Machine learning model improves accuracy of liquid biopsy results

Key protein behind chemotherapy resistance in colorectal cancer identified

Key protein behind chemotherapy resistance in colorectal cancer identified

Weight loss treatments linked to lower risk of obesity-related cancers in people without diabetes

Weight loss treatments linked to lower risk of obesity-related cancers in people without diabetes

Colorectal cancer risk linked to gut microbiome alterations

Colorectal cancer risk linked to gut microbiome alterations

American Cancer Society updates colorectal cancer screening guideline: Major changes emphasize blood-based and at-home stool testing

American Cancer Society updates colorectal cancer screening guideline: Major changes emphasize blood-based and at...

CHMP issues positive opinion for encorafenib in combination with cetuximab and FOLFOX for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer

CHMP issues positive opinion for encorafenib in combination with cetuximab and FOLFOX for the first-line treatment...

TGIF2-mediated HMGB3 overexpression drives oesophageal squamous cell carcinoma (ESCC)

TGIF2-mediated HMGB3 overexpression drives oesophageal squamous cell carcinoma (ESCC)

ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST

ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST

ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers

ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers

More from ecancer